Verified By IT Certified Experts
CertsTopics.com Certified Safe Files
Up-To-Date Exam Study Material
99.5% High Success Pass Rate
100% Accurate Answers
Instant Downloads
Exam Questions And Answers PDF
Try Demo Before You Buy
An international, nonprofit organization that establishes standards of best current practice for clinical laboratories is
Though it may not be required, TDM should still be used to confirm adequate dosing. Genotyping does not make TDM redundant.
A PM will metabolize the drug more slowly and therefore will need lower doses. CYP2D6 metabolizes many different drugs; it is not associated with just one class of drugs. Anytime a drug is taken that competes for the same metabolizing enzyme as another drug, there is potential for the concentrations of both drugs to be increased.
A patient has been characterized as a CYP2D6 poor metabolizer (PM) after genotyping. Which of the following statements is not true?
The intended response is "transfusion dimorphism". The microcytic, hypochromic erythrocytes suggests iron deficiency anemia. Interspersed among these cells are normocytic, normochromic erythrocytes suggesting two populations of red cells following transfusion. This was a case of severe iron deficiency treated with red cell transfusions and iron supplement.
The condition most likely associated with the peripheral blood picture in the photograph is: